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Manufacture of red blood cells (RBCs) from progenitors has been proposed as a method to reduce reliance on 
donors. Such a process would need to be extremely efficient for economic viability given a relatively low value 
product and high 2E12 cell dose. To achieve efficient process optimisation and scale-up an integrated approach 
comprising both experimentation and modelling is required.  
 
Using an automated stirred tank micro-bioreactor (ambr®, Sartorius Stedim, UK) we have shown that initially 
erythroblasts rapidly proliferate but then enter an inhibited growth phase. Experimentally we have confirmed that 
the conventional constraints on cell manufacturing efficiency, such as mass transfer, common metabolic 
limitations, or previously reported paracrine signals were not responsible for this inhibition. 
 
To further understand the mechanisms underlying the growth inhibition, we have used our own novel software 
interface, designed for the description, testing and manipulation of hypothetical dynamic mechanistic models. 
CD34+ cells derived from cord blood were grown in culture under erythroid expansion conditions. Cells were 
transferred to fresh culture medium and subject to different operating conditions. High time resolution growth 
curves were generated for each condition to distinguish between alternative models of growth and inhibition.  
The software, along with the experimental data, enabled a series of hypotheses regarding the mechanism of 
inhibition to be tested via the development of incrementally more complex mechanistic models based on the 
dominant phenomena involved in cell culture (e.g. substrate-dependent growth, cell death). Further experiments 
were performed under different operational conditions to test the predictive capabilities of the model and allow 
optimisation.  These iterations produced a relatively simple deterministic mechanistic model based on inhibitor 
production and decay that could predict erythroblast growth behaviour as a consequence of medium provision 
and cell density strategy.  
 
We have described an experimentally efficient approach to model key cell growth behaviour and operational 
consequences for manufacturing, which has general relevance across therapeutic cell culture systems where 
feedback signals are prevalent. The approach supports a high degree of confidence in manufacturing control 
due to mechanistic underpinnings and is complimentary to a hypothesis driven approach to further understand 
influences of cell growth. 
 
 
